Registration opens for “Best Practices” Conference
Register by January 4, 2023 for early bird pricing.
Register by January 4, 2023 for early bird pricing.
We recently sent our Pharmacy/Facility Members a magnet with a message to "stick it!"
The revised USP Chapter <797> related to sterile compounding, released on Tuesday, includes restrictions on beyond-use dates and batch size for CSPs that APC and others had argued were not supported by scientific evidence.
A proposed rule by the Delaware Board of Pharmacy has the potential to limit office stock compounding for veterinarians by 503A pharmacies. APC is submitting a comment letter and will be attending the board meeting on November 16.
The Pharmacy Compounding Foundation (PCF) will award up to two $2,500 scholarships in 2023 to pharmacy students who have demonstrated commitment to a career in compounding pharmacy in the US.
It has been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing.
APC member Jennifer Burch (owner of Central Compounding Center, Durham, NC) and APC CEO Scott Brunner recently did their part to clear the confusion regarding compounded hormone therapy and enhance awareness of its many benefits.
*By "win BIG" we mean that the knowledge you gain will help you be the best gosh darn compounding pharmacist you can be.
Assure your team has the current expertise it needs to practice with high competence and integrity by joining us for EduCon 2023 Virtual: Best Practices in Compounding.
It’s been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing. But "nothing" is a good thing.